Latest News

Recent addition to European flow diverter market performs well in multicentre...

A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...

Athersys announces changes to MASTERS-2 trial endpoints following US FDA meeting

Brainomix receives US FDA clearance for flagship stroke AI imaging software

COMMAND trial set to begin enrolment at third US site

UK MHRA awarded £10 million to fast-track patient access to medical...

Features

Female physicians in neurointerventional surgery: Breaking down barriers

In the latter stages of 2022, the Society of NeuroInterventional Surgery (SNIS) released a position statement advocating pregnancy and parental leave policies in neurointerventional...

NeuroNews’ top 10 most popular stories of February 2023

Stroke research was the flavour of the month throughout February on NeuroNews, with highlights from the International Stroke Conference (ISC; 8–10 February, Dallas, USA)...

Videos

Over 10 years of advancing clinical knowledge with Stryker’s Trevo Retriever

 At Stryker, we invest in clinical trials and registries to advance stroke care. In this video, Markus Möhlenbruch discusses the most significant studies that have demonstrated the safety and efficacy of Trevo Retrievers over the last decade. You can count on...

Events

Shelley Renowden

Isil Saatci

Pedro Lylyk

NeuroNews

Write to us
Editorial: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy